Search

Stephen L. Rawlings

Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )

Most Active Art Unit
1643
Art Unit(s)
1642, 1643, 1646
Total Applications
1483
Issued Applications
633
Pending Applications
153
Abandoned Applications
701

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7082670 [patent_doc_number] => 20050048050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth' [patent_app_type] => utility [patent_app_number] => 10/864818 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4195 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048050.pdf [firstpage_image] =>[orig_patent_app_number] => 10864818 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/864818
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth Jun 9, 2004 Issued
Array ( [id] => 5655232 [patent_doc_number] => 20060140967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Immunogenic peptides for the treatment of prostate and breast cancer' [patent_app_type] => utility [patent_app_number] => 10/559329 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22728 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140967.pdf [firstpage_image] =>[orig_patent_app_number] => 10559329 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559329
Immunogenic peptides for the treatment of prostate and breast cancer Jun 1, 2004 Issued
Array ( [id] => 7317566 [patent_doc_number] => 20040224347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Methods for identification, diagnosis, and treatment of breast cancer' [patent_app_type] => new [patent_app_number] => 10/858086 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11166 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224347.pdf [firstpage_image] =>[orig_patent_app_number] => 10858086 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/858086
Methods for identification, diagnosis, and treatment of breast cancer May 31, 2004 Abandoned
Array ( [id] => 7045105 [patent_doc_number] => 20050249700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling' [patent_app_type] => utility [patent_app_number] => 10/854000 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19796 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249700.pdf [firstpage_image] =>[orig_patent_app_number] => 10854000 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/854000
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling May 24, 2004 Abandoned
Array ( [id] => 7182919 [patent_doc_number] => 20040203012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Method of detecting and monitoring prostate and ovarian cancers' [patent_app_type] => new [patent_app_number] => 10/478333 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15448 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203012.pdf [firstpage_image] =>[orig_patent_app_number] => 10478333 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/478333
Method of detecting and monitoring prostate and ovarian cancers May 20, 2004 Abandoned
Array ( [id] => 7530560 [patent_doc_number] => 07842782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Heparanase-derived peptides for vaccination of tumor patients' [patent_app_type] => utility [patent_app_number] => 10/557249 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 2 [patent_no_of_words] => 5565 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842782.pdf [firstpage_image] =>[orig_patent_app_number] => 10557249 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557249
Heparanase-derived peptides for vaccination of tumor patients May 17, 2004 Issued
Array ( [id] => 7296248 [patent_doc_number] => 20040214289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Control of glycoforms in IgG' [patent_app_type] => new [patent_app_number] => 10/848421 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4382 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214289.pdf [firstpage_image] =>[orig_patent_app_number] => 10848421 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848421
Control of glycoforms in IgG May 17, 2004 Abandoned
Array ( [id] => 6918050 [patent_doc_number] => 20050095611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Identification of biomarkers for detecting pancreatic cancer' [patent_app_type] => utility [patent_app_number] => 10/836649 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29186 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095611.pdf [firstpage_image] =>[orig_patent_app_number] => 10836649 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/836649
Identification of biomarkers for detecting pancreatic cancer Apr 29, 2004 Abandoned
Array ( [id] => 7419182 [patent_doc_number] => 20040228871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Treatment and analysis of proliferative disorders' [patent_app_type] => new [patent_app_number] => 10/818906 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9353 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20040228871.pdf [firstpage_image] =>[orig_patent_app_number] => 10818906 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/818906
Treatment and analysis of proliferative disorders Apr 4, 2004 Abandoned
Array ( [id] => 7422078 [patent_doc_number] => 20040229260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Caspase-8 interacting proteins' [patent_app_type] => new [patent_app_number] => 10/814160 [patent_app_country] => US [patent_app_date] => 2004-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26809 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229260.pdf [firstpage_image] =>[orig_patent_app_number] => 10814160 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/814160
Caspase-8 interacting proteins Mar 31, 2004 Issued
Array ( [id] => 7230434 [patent_doc_number] => 20040156861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Melanoma associated peptide analogues and vaccines against melanoma' [patent_app_type] => new [patent_app_number] => 10/808681 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10825 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20040156861.pdf [firstpage_image] =>[orig_patent_app_number] => 10808681 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/808681
Melanoma associated peptide analogues and vaccines against melanoma Mar 24, 2004 Abandoned
Array ( [id] => 7286912 [patent_doc_number] => 20040146932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Prostate-specific gene, PCGEM1, and methods of using PCGEM1 to detect, treat, and prevent prostate cancer' [patent_app_type] => new [patent_app_number] => 10/802823 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12091 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146932.pdf [firstpage_image] =>[orig_patent_app_number] => 10802823 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/802823
Prostate-specific gene, PCGEM1, and methods of using PCGEM1 to detect, treat, and prevent prostate cancer Mar 17, 2004 Abandoned
Array ( [id] => 7287037 [patent_doc_number] => 20040146978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Isolated human Ras-like proteins, nucleic acid molecules encoding human Ras-like proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/800865 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20779 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146978.pdf [firstpage_image] =>[orig_patent_app_number] => 10800865 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/800865
Isolated human Ras-like proteins, nucleic acid molecules encoding human Ras-like proteins, and uses thereof Mar 15, 2004 Abandoned
Array ( [id] => 7323514 [patent_doc_number] => 20040137455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Diagnosis of cancer or benign tumor using the aberrant expression product of the klk4 gene' [patent_app_type] => new [patent_app_number] => 10/473485 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29931 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137455.pdf [firstpage_image] =>[orig_patent_app_number] => 10473485 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/473485
Diagnosis of cancer or benign tumor using the aberrant expression product of the klk4 gene Mar 14, 2004 Abandoned
Array ( [id] => 274066 [patent_doc_number] => 07560230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Method for determining susceptibility of tumor to treatment with anti-neoplastic agent' [patent_app_type] => utility [patent_app_number] => 10/546612 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21703 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560230.pdf [firstpage_image] =>[orig_patent_app_number] => 10546612 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/546612
Method for determining susceptibility of tumor to treatment with anti-neoplastic agent Mar 3, 2004 Issued
Array ( [id] => 7264810 [patent_doc_number] => 20040151725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'CTLA-4 immunoglobulin fusion proteins having modified effector functions and uses therefor' [patent_app_type] => new [patent_app_number] => 10/792637 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24514 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20040151725.pdf [firstpage_image] =>[orig_patent_app_number] => 10792637 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/792637
CTLA-4 immunoglobulin fusion proteins having modified effector functions and uses therefor Mar 1, 2004 Abandoned
Array ( [id] => 7275617 [patent_doc_number] => 20040235068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders' [patent_app_type] => new [patent_app_number] => 10/488033 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30969 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235068.pdf [firstpage_image] =>[orig_patent_app_number] => 10488033 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/488033
Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders Feb 26, 2004 Abandoned
Array ( [id] => 1077107 [patent_doc_number] => 07615623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'BAG proteins and nucleic acid molecules encoding them' [patent_app_type] => utility [patent_app_number] => 10/782627 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 31 [patent_no_of_words] => 10870 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615623.pdf [firstpage_image] =>[orig_patent_app_number] => 10782627 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/782627
BAG proteins and nucleic acid molecules encoding them Feb 17, 2004 Issued
Array ( [id] => 5153836 [patent_doc_number] => 20070036719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Prostate cancer diagnosis and treatment' [patent_app_type] => utility [patent_app_number] => 10/543572 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12915 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036719.pdf [firstpage_image] =>[orig_patent_app_number] => 10543572 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/543572
Prostate cancer diagnosis and treatment Jan 27, 2004 Issued
Array ( [id] => 7675311 [patent_doc_number] => 20040126807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor' [patent_app_type] => new [patent_app_number] => 10/758377 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 46103 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126807.pdf [firstpage_image] =>[orig_patent_app_number] => 10758377 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/758377
Compositions and methods for the diagnosis and treatment of tumor Jan 14, 2004 Abandoned
Menu